Swiss Primary Sclerosing Cholangitis Cohort Study

NCT ID: NCT03146936

Last Updated: 2025-08-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-02-28

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Research project in which biological material is sampled and health-related personal data is further used and collected.

Coded data are used.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators wish to collect high quality prospective data on a rare disease in order to elucidate epidemiology, natural history, response to treatment and outcome. In addition, a biobank allows addressing specific scientific issues on a variety of open questions. The cohort will provide a platform for carrying out scientific research projects on PSC. In addition, the cohort will allow collaborations with reference networks on PSC abroad

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cholangitis, Sclerosing PSC Primary Sclerosing Cholangitis (PSC)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed with PSC according to established criteria (European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases) of any age. Patients not fulfilling such criteria but still diagnosed with PSC in a hepatology referral centre can be included
* patients living in Switzerland

Exclusion Criteria

* N/A
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondazione Epatocentro Ticino

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fondazione Epatocentro Ticino

Lugano, Canton Ticino, Switzerland

Site Status RECRUITING

Gastroenterologie und Hepatologie Clarunis - Universitäres Bauchzentrum Universitätsspital Basel

Basel, , Switzerland

Site Status RECRUITING

Universitäts-Kinderspital beider Basel UKBB, Gastroenterologie&Ernährung

Basel, , Switzerland

Site Status RECRUITING

Inselspital

Bern, , Switzerland

Site Status RECRUITING

Kinderklinik, INSELSpital, Universität Bern, Pädiatrische Gastroenterologie, Hepatologie und Ernährung

Bern, , Switzerland

Site Status RECRUITING

Spital Bülach

Bülach, , Switzerland

Site Status RECRUITING

Kantonsspital Graubünden

Chur, , Switzerland

Site Status RECRUITING

Hôpitaux Universitaires de Genève, Centre Suisse des Maladies du foie de l'Enfant- Département de l'Enfant et de l'Adolescent

Geneva, , Switzerland

Site Status RECRUITING

Hôpitaux Universitaires de Genève, Service de Gastroentérologie & Hépatologie, Département des Spécialités

Geneva, , Switzerland

Site Status RECRUITING

CHUV: Centre hospitalier universitaire vaudois

Lausanne, , Switzerland

Site Status RECRUITING

CHUV Département femme-mère-enfant

Lausanne, , Switzerland

Site Status RECRUITING

Kantonsspital Baselland

Liestal, , Switzerland

Site Status RECRUITING

Kinderspital Luzern LUKS, Pädiatrische Gastroenterologie

Lucerne, , Switzerland

Site Status RECRUITING

Luzerner Kantonsspital

Lucerne, , Switzerland

Site Status RECRUITING

EOC Ospedale Regionale di Lugano - Italiano

Lugano, , Switzerland

Site Status RECRUITING

Ostschweizer Kinderspital

Sankt Gallen, , Switzerland

Site Status RECRUITING

Kantonsspital St.Gallen

Sankt Gallen, , Switzerland

Site Status RECRUITING

Kantonsspital Winterthur

Winterthur, , Switzerland

Site Status RECRUITING

Pädiatrische Gastroenterologie Departement Kinder- und Jugendmedizin Kantonsspital Winterthur

Winterthur, , Switzerland

Site Status RECRUITING

Universitäts-Kinderspital Zürich - Eleonorenstiftung

Zurich, , Switzerland

Site Status RECRUITING

Universitätsspital Zürich

Zurich, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Andreas Cerny, Prof. Dr. med

Role: CONTACT

+41 91 910 6570

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Andreas Cerny, Prof. Dr. med

Role: primary

+41 91 910 6570

Christine Bernsmeier, PD Dr. med. Dr. phil.

Role: primary

+41 61 777 7400

Raoul Furlano, PD MD

Role: primary

+4161 704 12 13

Maria Gabriela Delgado, MD

Role: primary

+4131 632 09 00

Christiane Sokollik, MD

Role: primary

+4131 632 50 93

Stephan Böhm, Prof. Dr. med

Role: primary

+41 44 863 24 30

Simon Brunner, Dr. med.

Role: primary

+41 81 256 63 07

Valérie McLin, Prof.

Role: primary

+4122 382 45 72

Giulia Magini, Dr. med.

Role: primary

+41 22 372 93 40

Montserrat Fraga Christinet

Role: primary

+41 21 314 04 33

Andreas Nydegger, MD

Role: primary

+41 21 314 11 11

Magdalena Filipowicz-Sinnreich, MD

Role: primary

+41 61 925 23 60

Franziska Righini-Grunder, Dr. med.

Role: primary

+4141 205 32 09

Andrea De Gottardi, Prof. Dr. med

Role: primary

+41 41 205 21 31

Benedetta Terziroli Beretta-Piccoli, MD

Role: primary

+41 91 811 7637

Pascal Müller, MD

Role: primary

+4171 243 13 44

David Semela, MD

Role: primary

+4171 4941216

Björn Becker, MD

Role: primary

+41 052 266 21 21

Klaas Heyland, Dr. med.

Role: primary

+41 522663452

Carsten Posovszky, Prof. Dr. med

Role: primary

+41 44 249 60 41

Andreas Kremer, Prof. Dr. med

Role: primary

+41 44 255 85 48

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SASL40 - Swiss PSC Cohort

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.